» Authors » Sandra M Zurawski

Sandra M Zurawski

Explore the profile of Sandra M Zurawski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 1242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Coleon S, Wiedemann A, Surenaud M, Lacabaratz C, Hue S, Prague M, et al.
EBioMedicine . 2022 May; 80:104062. PMID: 35594660
Background: There is an urgent need of a new generation of vaccine that are able to enhance protection against SARS-CoV-2 and related variants of concern (VOC) and emerging coronaviruses. Methods:...
2.
Cheng L, Li G, Pellegry C, Yasui F, Li F, Zurawski S, et al.
Front Immunol . 2021 Jun; 12:672143. PMID: 34093572
Mice reconstituted with a human immune system (humanized mice) provide a robust model to study human immunology, vaccinology, and human infectious diseases. However, the development and function of B cells...
3.
Godot V, Tcherakian C, Gil L, Cervera-Marzal I, Li G, Cheng L, et al.
PLoS Pathog . 2020 Nov; 16(11):e1009025. PMID: 33253297
The development of HIV-1 vaccines is challenged by the lack of relevant models to accurately induce human B- and T-cell responses in lymphoid organs. In humanized mice reconstituted with human...
4.
Bouteau A, Kervevan J, Su Q, Zurawski S, Contreras V, Dereuddre-Bosquet N, et al.
Front Immunol . 2019 Jun; 10:1134. PMID: 31191525
To determine the contribution of skin DC subsets in the regulation of humoral immunity, we used a well-characterized antigen targeting system to limit antigen availability and presentation to certain skin-derived...
5.
Cheng L, Zhang Z, Li G, Li F, Wang L, Zhang L, et al.
Vaccine . 2017 Sep; 35(45):6143-6153. PMID: 28958808
TLR ligands (TLR-Ls) represent a class of novel vaccine adjuvants. However, their immunologic effects in humans remain poorly defined in vivo. Using a humanized mouse model with a functional human...
6.
Graham J, Authie P, Yu C, Zurawski S, Li X, Marches F, et al.
Vaccine . 2016 Sep; 34(41):4857-4865. PMID: 27595442
The targeting of vaccine antigens to antigen presenting cells (APC), such as dendritic cells (DCs), is a promising strategy for boosting vaccine immunogenicity and, in turn, protective and/or therapeutic efficacy....
7.
Yao C, Zurawski S, Jarrett E, Chicoine B, Crabtree J, Peterson E, et al.
J Allergy Clin Immunol . 2015 May; 136(5):1387-97.e1-7. PMID: 25962902
Background: The contribution of individual subsets of dendritic cells (DCs) to generation of adaptive immunity is central to understanding immune homeostasis and protective immune responses. Objective: We sought to define...
8.
Kashem S, Igyarto B, Gerami-Nejad M, Kumamoto Y, Mohammed J, Jarrett E, et al.
Immunity . 2015 Feb; 42(2):356-366. PMID: 25680275
Candida albicans is a dimorphic fungus responsible for chronic mucocutaneous and systemic infections. Mucocutaneous immunity to C. albicans requires T helper 17 (Th17) cell differentiation that is thought to depend...
9.
Skinner J, Zurawski S, Sugimoto C, Vinet-Oliphant H, Vinod P, Xue Y, et al.
Clin Vaccine Immunol . 2014 Oct; 21(12):1668-80. PMID: 25298110
Despite the availability of annually formulated vaccines, influenza virus infection remains a worldwide public health burden. Therefore, it is important to develop preclinical challenge models that enable the evaluation of...
10.
Flamar A, Xue Y, Zurawski S, Montes M, King B, Sloan L, et al.
AIDS . 2013 Apr; 27(13):2041-51. PMID: 23615121
Objective: Targeting HIV antigens directly to dendritic cells using monoclonal antibodies against cell-surface receptors has been shown to evoke potent cellular immunity in animal models. The objective of this study...